+ All Categories
Home > Documents > Chasing fluid away… case report Mr Jordi López-Alvarez LltVet MRCVS Resident in Internal Medicine...

Chasing fluid away… case report Mr Jordi López-Alvarez LltVet MRCVS Resident in Internal Medicine...

Date post: 27-Dec-2015
Category:
Upload: stephany-bryant
View: 215 times
Download: 1 times
Share this document with a friend
Popular Tags:
23
Chasing fluid away… Chasing fluid away… case report case report Mr Jordi López-Alvarez LltVet MRCVS Resident in Internal Medicine (Cardiology) Small Animal Teaching Hospital, University of Liverpool Leahurst, Chester High Road, Neston
Transcript

Chasing fluid away…Chasing fluid away…case reportcase report

Mr Jordi López-Alvarez LltVet MRCVSResident in Internal Medicine (Cardiology)

Small Animal Teaching Hospital, University of LiverpoolLeahurst, Chester High Road, NestonCheshire CH64 7TE, United Kingdom

Presentation: June 2009

FLOYD

4 yo GSD NM

Referred for tachycardia (non-responsive to lidocaine)

Anamnesis:

Progressive (over 1 month):exercise intolerance

tachypnoea

No history of previous illnesses was reported

Up-to-date with worming and vaccinations

Presentation: June 2009

Physical examination:• 36.4 kg

• Tachypnoea (44 rpm)

• Mild abdominal distension with fluid thrill

• Positive hepatojugular reflux

• Chaotic rhythm and rate at 240 bpm

• Marked pulse deficits at 100/min

• Variable 2-3/6 left apical systolic murmur

Presentation: June 2009

Diagnostic work-up

Haematology and biochemistry: NAD

Cardiac troponin I: 1.18 ng/mL (ref. value <0.15)

Blood pressure: 150 mmHg

Electrocardiography

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 1716 1918 20

Thoracic X-rays

Doppler echocardiography

Doppler echocardiography

Diagnosis

Myxomatous degenerative valvular disease1

secondary myocardial failure

atrial fibrillation

congestive heart failure

1 Borgarelli M, Zini E, D'Agnolo G, et al. Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds.J Vet Cardiol 2004;6:27-34.

Diuresis: sequential nephron blockade

ACEi

Pimobendan

Spironolactone

Others: antiarrhythmics, afterload

reduction...

CHF Treatment

Treatment

Hospitalisation over the week-end:

IV furosemide q 2-4h (until RR<40bpm)

Rate control: digoxin and diltiazem

At dischargeCHF:

Furosemide 1.5 mg/kg TID

Pimobendan 0.3 mg/kg BID

Benazepril 0.5 mg/kg SID

Spironolactone 1 mg/kg SIDRate control:

Digoxin 0.125 mg/dog BID (0.003 mg/kg BID!!)

Diltiazem 2 mg/kg TID

Sequential nephron blockade

Sodium transport:•Proximal tubule: 60%

(cotransported with glucose, amino acids or phosphate)

•Loop of Henle: 30% (Na+-K+-2Cl- carrier)

•Distal convoluted tubule: 7% (Na+-Cl- cotransporter)

•Collecting duct: 3% (aldosterone)

Na2Cl

Na

NaCl

NaK

Loopdiuretics

Aldosteroneinhibitors

Thiazides

Spironolactone

Weak diuretic effect

Anti-aldosterone:

• Potassium sparing effect

• Anti-remodelling

Reduces cardiac morbidity and mortality2

2 Bernay F, Bland JM, Häggström J, et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med 2010;24:331-341.

Torasemide vs. Furosemide

Longer half life (6h vs 4h)

More potent diuretic effect

Anti-aldosterone:• Potassium sparing effect• Anti-remodelling

Better oral absorption (absorption of furosemide but not torasemide is delayed in CHF)

No Clinical trials in Veterinary medicine

Furosemide 2 mg/kg QID

Spironolactone 1 mg/kg SID

Hydrochlorthiazide + Amiloride 0.5 mg/kg

BID

Torasemide 0.25 mg/kg BID

CHF Treatment

DIGOXIN

+/- DILTIAZEM

Recommendation:0.003 mg/kg BID and check the trough levels 1 week after

Lab ref: 1.0 - 2.4

Aimed levels 0.5 – 1.2

RATE vs RYTHM Control

AMLODIPINE

Dihydropyridine class calcium channel blockerPeripheral vasodilation antihypertensive

Ao = 50%

MR = 50%

Ao = 80%

MR = 20%

• Risk

If hypotension:• Tachycardia

• RAAS activation

Palliative abdominocentesis

Respiration rate at home

Body weight!!

Biochemistry: renal function?

Holter monitor: rate control?

Radiographs: Left Side-CHF?

Echo: Pulmonary hypertension

Monitoring

Monitoring

cTroponin I Abdominocentesis Digoxin Holter

Conclusions

Owner commitment

Quality vs. Quantity of Life

Adequate monitoring

Pathophysiology and

therapeutics knowledge

Thank you!


Recommended